Welcome to New Frontiers, the podcast where Hemostasis meets innovation. In this second episode, I’m joined by Dr. Marco Foracchia, Chief Information Officer at Azienda Unità Sanitaria Locale – IRCCS Reggio Emilia, for an insightful conversation on cybersecurity in healthcare. Together we’ll uncover why hospitals are prime targets for cyberattacks, the specific vulnerabilities they face, and how data protection compares across critical sectors. We’ll also break down common attack methods and practical strategies to prevent and respond to threats. Tune in to discover key insights and best practices for navigating today’s cybersecurity challenges in one of the most complex sectors.
Welcome to New Frontiers, the podcast where Hemostasis meets cutting-edge innovation. In our debut episode, we dive into the world of data with Dr. Panagiotis Tsiamyrtzis, a leading voice in Statistical Process Control and Bayesian methods, teaching at Politecnico di Milano and the Athens University of Economics and Business. Together, we’ll explore the strengths and limitations of Frequentist versus Bayesian approaches, and discover how Bayesian models—adaptive, self-starting, and powered by prior knowledge—can revolutionize Quality Control, especially when data is scarce. Tune in and find out how smart statistics are reshaping the future of Hemostasis.
I’m Nusaiba, at 20 I had a two pulmonary embolism 10 months apart while studying at university. It was devastating and impacted every aspect of my life, I was completely unaware of how difficult recovery can be and did not know anything about some of the unexpected side effects of blood thinners. Four years down the line, I have had to adjust to a new normal where life involves a lot of hospital appointments! As a young person with a clot I had to navigate recovery while finishing my degree and now working full time, while also trying to enjoy life as a young person! I hope by sharing my story both patients and clinicians will learn about the complexities of having blood clots and that recovery can be very hard but you will get better!
I’m Priyanka Sardana-Gakhar—friends call me Priya—a 29-year-old soccer player from Sydney, Australia. At 22, I earned a scholarship to play NCAA D1 in the U.S. and moved to Louisiana. My life took a sharp turn after a 14-hour flight back to cold Canberra, where I was diagnosed with multiple blood clots in my lungs. As an athlete, it’s easy to dismiss symptoms, and often, others do too. I’m sharing my story to make sure no one else goes through this, and to remind everyone to keep pushing for answers, no matter what.
I’m Ellie Bradford, 24, from the UK. I had my first blood clot at just 16 years old due to May-Thurner Syndrome and the combined pill, and another unprovoked DVT at 24. Now on lifelong blood thinners, I want to raise awareness that blood clots can happen to anyone. Sharing my story is my way of helping others recognize the signs and push for the right diagnosis.
Lainey is a research technician for an Alzheimer's and Aging Laboratory. She graduated from Iowa State University with her bachelor’s degree in Animal Science. While at Iowa State, Lainey experienced two clotting events. Lainey is a proud, two time pulmonary embolism survivor. A latin proverb states,“by teaching, we learn”. Lainey uses this phrase to influence her personal life and her life spreading awareness around the risks, signs and symptoms of blood clots. When she isn’t in the laboratory, you can find Lainey with a camera in hand photographing pets and wildlife, or at home baking and crafting with her two labradors and three orange kitties by her side.
Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the final episode of our podcast series on Women and Bleeding Disorders, we close our discussion with Dr. Lucia Rugeri, a specialist in clinical hemostasis, discussing the challenges of the management of bleeding disorders with special attention to challenges faced in the management of women-specific conditions. We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.
Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the third episode of our podcast series on Women and Bleeding Disorders, we continue exploring with Dr. Lucia Rugeri, a specialist in clinical hemostasis, what is the situation of Patient Access to care, the state of the Education of patients and healthcare professionals on the topic, and how to Diagnose Bleeding Disorders with a special focus on women.We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.
Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. The second episode of our podcast series on Women and Bleeding Disorders is an interview with Dr. Lucia Rugeri, a specialist in clinical hemostasis, who has dedicated her career to caring for women with bleeding and thrombotic disorders who will share with us the situation in terms of numbers of bleeding disorders with a special focus on women.We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.
Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. We are happy to introduce you to our podcast series on Women and Bleeding Disorders. Our first episode is an interview with Naja Skow Rasmussen to share her personal story as a patient dealing with a bleeding disorder and her journey of advocacy to find effective solutions for all patients who suffer from bleeding disorders.We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays
Episode 6: In the history of Hemostasis, laboratory testing has contributed immensely to the ability of healthcare professionals to deliver the proper care. Automated instruments have revolutionized the way Labs and Lab technicians deliver results and we will be sharing the backstage of the launch of the first automated analyzer for coagulation. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
Episode 5: In the history of Hemostasis, laboratory testing has contributed immensely to the ability of healthcare professionals to deliver the proper care. One type of assays for hemostasis is Chromogenic assays and in this episode, we will review the impact these assays have had. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
Episode 4: In the history of Hemostasis, the impact of Heparin in all its formats (unfractionated or low molecular weight) has had a significant impact as an anticoagulant for the management of thrombophilic and thrombotic conditions and the history of how it started to where we are today is worth sharing. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
Episode 3: In the history of Hemostasis, the discovery of Von Willebrand Factor and its cleaving protease ADAMTS13 has expanded our understanding of primary hemostasis and the bleeding and thrombotic disorders associated with defects of either component of this axis. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
Episode 2:In the history of Hemostasis, D-Dimer has evolved from a marker of fibrinolysis to several clinical use cases to help guide the diagnosis and the management of patients suspected of Venous Thromboembolism, disseminated intravascular coagulation, or guide anticoagulation therapy. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
Episode 1: In the history of Hemostasis, the impact of Warfarin on patient outcomes for the prevention of blood clots is immeasurable and the way this drug became a mainstay of anticoagulation therapy is quite a unique journey worth sharing. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.